Cibc World Markets Corp Buys 1,317 Shares of Waters Co. (NYSE:WAT)

Cibc World Markets Corp boosted its stake in shares of Waters Co. (NYSE:WAT) by 16.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,373 shares of the medical instruments supplier’s stock after purchasing an additional 1,317 shares during the quarter. Cibc World Markets Corp’s holdings in Waters were worth $3,477,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Advisory Alpha LLC boosted its position in Waters by 2.6% during the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier’s stock valued at $395,000 after purchasing an additional 27 shares in the last quarter. Summit Trail Advisors LLC boosted its position in Waters by 2.4% during the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock valued at $431,000 after purchasing an additional 28 shares in the last quarter. Empowered Funds LLC boosted its position in Waters by 3.0% during the fourth quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier’s stock valued at $358,000 after purchasing an additional 28 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. boosted its position in Waters by 0.3% during the fourth quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier’s stock valued at $3,565,000 after purchasing an additional 30 shares in the last quarter. Finally, OneDigital Investment Advisors LLC boosted its holdings in Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after acquiring an additional 31 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on WAT shares. Bank of America lowered their price target on Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a report on Thursday, February 13th. Wells Fargo & Company raised their price target on Waters from $415.00 to $420.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. StockNews.com downgraded Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. JPMorgan Chase & Co. raised their price target on Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Finally, Barclays raised Waters from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $360.00 to $415.00 in a report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Waters presently has an average rating of “Hold” and a consensus price target of $391.07.

Waters Stock Down 2.1 %

Shares of WAT stock opened at $363.44 on Friday. The stock has a 50 day moving average of $391.11 and a 200 day moving average of $370.92. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The stock has a market cap of $21.59 billion, a P/E ratio of 33.93, a P/E/G ratio of 3.79 and a beta of 1.00. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56.

Waters (NYSE:WAT) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. As a group, sell-side analysts expect that Waters Co. will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.